About us Pricing ContactSubscribe

R

Roy S. Herbst

Astex PharmaceuticalsORCID https://orcid.org/0000-0003-2535-5847

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

The Lancet20156,477 citationsFirst authorCorresponding

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer

Journal of Clinical Oncology20041,949 citations

Review of epidermal growth factor receptor biology

International Journal of Radiation Oncology*Biology*Physics20041,397 citationsFirst authorCorresponding

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Clinical Cancer Research20121,115 citations